How AI Is Making Biotech Safer – Expert Talk With Kelly Randis From Gamida Cell
We’re seeing a revolution in how we protect our data and systems, driven by rapidly evolving threats and the need for more sophisticated defenses.
Our guest, Kelly Randis, Head of Global Information Technology at Gamida Cell Ltd., brings over three decades of IT expertise, primarily in the pharmaceutical industry. We discuss how AI is reshaping security protocols in biotech, addressing both the challenges and advancements this integration presents.
We also examine the broader implications of AI in IT infrastructure and strategies companies can employ to safeguard sensitive data against an increasing array of cyber-attacks.
Tune in to gain valuable insights into the critical role of technology in enhancing operational efficiency and securing data in the biotechnology sector.
Specifically, this episode highlights the following themes:
- Integration of AI in cybersecurity
- Building robust IT infrastructures in biotech
- Strategies for safeguarding against phishing and ransomware attacks
Links from this episode:
- Get to know more about Steven Swan: https://www.linkedin.com/in/swangroup
- Get to know more about Kelly Randis: https://www.linkedin.com/in/kellyarandis
- Learn more about Gamida Cell Ltd. :https://www.gamida-cell.com
==== Time Stamps ====
00:00 – Introduction
00:47 – About Kelly Randis
03:13 – Integration of AI in various aspects of biotech and IT
06:47 – Conversation about the profitability of ransomware for cybercriminals
09:11 – Discussion about the potential of AI to revolutionize the biotech industry
13:09 – The necessity for large datasets to effectively train AI in security applications
15:08 – Discussion about Microsoft’s and other tech giants’ involvement in AI
19:16 – Potential applications of blockchain technology in securing medical data
